Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC).

Bibliographic Details
Main Authors: Shujuan Pan, Xiaoyun Cheng, Hongan Chen, Patricia D. Castro, Michael M. Ittmann, Anne W. Hutson, Susan K. Zapata, Richard N. Sifers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3879398

Similar Items